Gainesville, FL, United States of America

Dongwen Lyu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Florida Research Foundation Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongwen Lyu

Introduction

Dongwen Lyu is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of therapeutic agents and methods of treatment. His work focuses on developing compounds that can modulate proliferation activity and treat various diseases and disorders.

Latest Patents

Dongwen Lyu holds 1 patent for his invention titled "Therapeutic agents and methods of treatment." This patent is directed towards specific compounds, including Formula (I) or its pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. The invention details the mechanism of action of these compounds and outlines methods for their application in treating various health conditions.

Career Highlights

Dongwen Lyu is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore innovative solutions in the medical field. His research has the potential to impact the treatment of numerous diseases, showcasing his dedication to advancing healthcare.

Collaborations

Dongwen Lyu has collaborated with notable colleagues, including Guangrong Zheng and Daohong Zhou. These partnerships have fostered a collaborative environment that enhances the research and development of therapeutic agents.

Conclusion

Dongwen Lyu's contributions to the field of therapeutic agents exemplify the importance of innovation in medicine. His patent and ongoing research hold promise for improving treatment options for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…